Over the last four or five years, while teaching pharmacology to students during his graduate program at UC Santa Barbara, doctoral candidate Willus Fisher noted a persistent problem. “Every year, I ...

ATLANTA — Artificial intelligence is revolutionizing drug development, significantly reducing the time it takes to bring life-saving treatments to market, drug companies say. Traditionally, developing ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

Local and international trials The new technology – currently a prototype – is being trialled by drug services both in the UK and internationally. Devon & Cornwall Police, UK A device acquired by ...

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...

A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...

Researchers from the University of Adelaide have developed a new technology for drug and functional genomics screenings, which could reshape the way diseases are treated. The technology called dFLASH ...

SEMINOLE COUNTY, Fla. — Today in Seminole County, Florida, a new technology named ‘Drug Alert AI’ was introduced to help address the drug crisis by identifying threats early before they become lethal.

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The pharmaceutical industry faces the challenge of balancing innovation with affordability.

Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the filing of a divisional patent application for its Trap & Target (T&T) platform technology with the Israel Patent Office.